Analysts think Intel’s commentary signaled openness to cutting its foundry business later on, but for now there’s uncertainty ...

Lyell Immunopharma shares were 21% higher, at $12.57, after the company entered into a securities purchase agreement for a private placement with institutional and other accredited investors, for ...

The financial report of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) for the first half 2025 was filed with the French Financial Markets Authority (Autorité des marchés financiers) on July 25, ...

As MarketWatch noted earlier, the S&P 500 was on track on Friday to tally what would be its fifth straight record finish. Assuming this milestone comes to pass, it would mark the longest streak of ...

Omeros shares were 20% higher, at $4.31, after the company entered into a securities purchase agreement with Polar Asset Management Partners to sell $22 million of its common stock in a registered ...

When you hit your 50s, 60s or 70s, odds are good that you’ll be going to the hospital for a scheduled surgery or procedure. I ...

U.S. money supply is starting to accelerate again after returning close to trend, with aggregate monetary conditions suggesting the Federal Reserve’s policy stance is “only modestly restrictive,” ...

U.S. stocks opened higher on Friday, with the S&P 500 pushing toward a fifth straight record close. The Nasdaq Composite was little changed in early going, but if it manages to finish in the green, it ...

Separately, Sareptea said last week that it would pause the development of most of its experimental gene therapies for a different type of muscular dystrophy. The stoppage came after one of the ...

A team of strategists at Ned Davis Research has spotted a potentially troubling development beneath the surface of the S&P 500. Relative breadth among cyclical sectors in the index has started to ...